1959
DOI: 10.1016/0002-9343(59)90402-4
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial endotoxin in the genesis of experimental chronic pyelonephritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1962
1962
1968
1968

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Weyrauch, Rosenberg, Amar, and Redor observed amelioration of obstructive Escherichia coli pyelonephritis in rabbits immunized with an autogenous vaccine; however, the protection was only "slight" (13). Braude and Siemienski have recently reported experiments demonstrating protection against hematogenous pyelonephritis in rats immunized with either Escherichia coli or Proteus mirabilis endotoxin; the only evidence advanced to indicate that this protection is a result of specific immunity is a reference to a preliminary report of our work concerning both protection by passively transferred antibody and the specificity of such protection (3,14). Conclusions regarding development of circulating antibodies during the course of either experimental or clinical pyelonephritis have been controversial.…”
Section: (From the Department Of Internal Medicine The University Ofmentioning
confidence: 99%
“…Weyrauch, Rosenberg, Amar, and Redor observed amelioration of obstructive Escherichia coli pyelonephritis in rabbits immunized with an autogenous vaccine; however, the protection was only "slight" (13). Braude and Siemienski have recently reported experiments demonstrating protection against hematogenous pyelonephritis in rats immunized with either Escherichia coli or Proteus mirabilis endotoxin; the only evidence advanced to indicate that this protection is a result of specific immunity is a reference to a preliminary report of our work concerning both protection by passively transferred antibody and the specificity of such protection (3,14). Conclusions regarding development of circulating antibodies during the course of either experimental or clinical pyelonephritis have been controversial.…”
Section: (From the Department Of Internal Medicine The University Ofmentioning
confidence: 99%